T 1561/17 (Coumarin therapeutic target/BAXALTA) of 27.11.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T156117.20171127
- Date of decision
- 27 November 2017
- Case number
- T 1561/17
- Petition for review of
- -
- Application number
- 10011278.8
- IPC class
- C12N 9/04
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives
- Applicant name
- Baxalta Incorporated
Baxalta GmbH - Opponent name
- Emergent BioSolutions Inc.
Cangene Corporation - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 113(2)
- Keywords
- Basis for a decision on the appeal (no) - revocation of the patent
- Catchword
- -
- Citing cases
- T 0344/15
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.